Current State and Local Tax Expense (Benefit) of ENZON PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
ENZON PHARMACEUTICALS, INC. annual and quarterly Current State and Local Tax Expense (Benefit) in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • ENZON PHARMACEUTICALS, INC. Current State and Local Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $2,000, unchanged year-over-year.
  • ENZON PHARMACEUTICALS, INC. annual Current State and Local Tax Expense (Benefit) for 2025 was $2,000, a 60% decline from 2024.
  • ENZON PHARMACEUTICALS, INC. annual Current State and Local Tax Expense (Benefit) for 2024 was $5,000.
Source SEC data
View on sec.gov
Current State and Local Tax Expense (Benefit), Annual (USD)
Current State and Local Tax Expense (Benefit), YoY Annual Change (%)
Current State and Local Tax Expense (Benefit), Quarterly (USD)
Current State and Local Tax Expense (Benefit), YoY Quarterly Change (%)

ENZON PHARMACEUTICALS, INC. Annual Current State and Local Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,000 -$3,000 -60% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 $5,000 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
2010 $200,000 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY

ENZON PHARMACEUTICALS, INC. Quarterly Current State and Local Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q1 2024 $2,000 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.